Vanguard Discloses 15.0% Stake in Axogen (AXGN)

Ticker: AXGN · Form: SC 13G · Filed: Feb 13, 2024 · CIK: 805928

Axogen, Inc. SC 13G Filing Summary
FieldDetail
CompanyAxogen, Inc. (AXGN)
Form TypeSC 13G
Filed DateFeb 13, 2024
Risk Levellow
Pages3
Reading Time3 min
Sentimentbullish

Complexity: simple

Sentiment: bullish

Topics: institutional-ownership, passive-investment, stake-disclosure

TL;DR

**Vanguard just revealed a 15% stake in Axogen, a big vote of confidence!**

AI Summary

The Vanguard Group, a major investment firm, reported on February 13, 2024, that it beneficially owns 7,006,759 shares of Axogen, Inc. (NASDAQ: AXGN) common stock as of December 29, 2023. This represents 15.0% of Axogen's total outstanding shares. This matters to investors because Vanguard's significant stake indicates a strong institutional belief in Axogen's long-term prospects, potentially signaling stability and future growth for the medical device company.

Why It Matters

Vanguard's substantial ownership stake in Axogen signals institutional confidence, which can be a positive indicator for current and prospective shareholders.

Risk Assessment

Risk Level: low — This filing indicates a large institutional investor has a significant stake, generally reducing perceived risk due to professional oversight.

Analyst Insight

A smart investor would view Vanguard's significant 15.0% stake as a positive signal, potentially indicating long-term value in Axogen, and might consider further research into Axogen's fundamentals and growth prospects.

Key Numbers

  • 7,006,759 — Shares Beneficially Owned (Represents Vanguard's total holding in Axogen common stock.)
  • 15.0% — Percentage of Class (Indicates the significant portion of Axogen's common stock owned by Vanguard.)
  • 20240213 — Filing Date (The date this SC 13G filing was made public.)
  • 05463X106 — CUSIP Number (Unique identifier for Axogen, Inc. Common Stock.)

Key Players & Entities

  • The Vanguard Group (company) — reporting person and beneficial owner
  • Axogen, Inc. (company) — issuer of the securities
  • 7,006,759 (dollar_amount) — number of shares beneficially owned
  • 15.0% (dollar_amount) — percentage of class beneficially owned
  • December 29, 2023 (date) — date of event requiring filing

Forward-Looking Statements

  • Vanguard will maintain or slightly increase its stake in Axogen over the next year. (The Vanguard Group) — medium confidence, target: 2025-02-13

FAQ

What is the primary purpose of this SC 13G filing?

This SC 13G filing, submitted by The Vanguard Group, serves to disclose their beneficial ownership of 7,006,759 shares, representing 15.0% of Axogen, Inc.'s common stock, as required by Rule 13d-1(b) of the Securities Exchange Act of 1934.

Who is the reporting person in this filing, and what is their IRS Identification Number?

The reporting person is The Vanguard Group, and their I.R.S. Identification Number is 23-1945930, as stated in Item 1 of the filing.

What is the CUSIP Number for Axogen, Inc. Common Stock mentioned in the filing?

The CUSIP Number for Axogen, Inc. Common Stock is 05463X106, as specified on the cover page and in the body of the Schedule 13G.

What was the 'Date of Event Which Requires Filing of this Statement'?

The 'Date of Event Which Requires Filing of this Statement' was December 29, 2023, according to the filing.

Under which specific rule of the Securities Exchange Act of 1934 was this Schedule 13G filed?

This Schedule 13G was filed under Rule 13d-1(b) of the Securities Exchange Act of 1934, as indicated by the checked box on the cover page.

Filing Stats: 805 words · 3 min read · ~3 pages · Grade level 11.6 · Accepted 2024-02-13 16:58:58

Filing Documents

(a) - Name of Issuer

Item 1(a) - Name of Issuer: Axogen Inc

(b) - Address of Issuer's Principal Executive Offices

Item 1(b) - Address of Issuer's Principal Executive Offices: 13631 Progress Boulevard, Suite 400 Alachua, FL 32615

(a) - Name of Person Filing

Item 2(a) - Name of Person Filing: The Vanguard Group - 23-1945930

(b) – Address of Principal Business Office or, if none, residence

Item 2(b) – Address of Principal Business Office or, if none, residence: 100 Vanguard Blvd. Malvern, PA 19355

(c) – Citizenship

Item 2(c) – Citizenship: Pennsylvania

(d) - Title of Class of Securities

Item 2(d) - Title of Class of Securities: Common Stock

(e) - CUSIP Number

Item 2(e) - CUSIP Number 05463X106

- Type of Filing

Item 3 - Type of Filing: This statement is being filed pursuant to Rule 13d-1. An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E).

- Ownership

Item 4 - Ownership: (a) Amount Beneficially Owned: (b) Percent of Class: (c) Number of shares as to which such person has: (i) sole power to vote or direct to vote: (ii) shared power to vote or direct to vote: (iii) sole power to dispose of or to direct the disposition of: (iv) shared power to dispose or to direct the disposition of: Comments: The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.

- Ownership of Five Percent or Less of a Class

Item 5 - Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following

- Ownership of More Than Five Percent on Behalf of Another Person

Item 6 - Ownership of More Than Five Percent on Behalf of Another Person: The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%. Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company: Not applicable

- Identification and Classification of Members of Group

Item 8 - Identification and Classification of Members of Group: Not applicable

- Notice of Dissolution of Group

Item 9 - Notice of Dissolution of Group: Not applicable

- Certification

Item 10 - Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 13, 2024 By /s/ Ashley Grim Name: Ashley Grim Title: Head of Global Fund Administration

View Full Filing

View this SC 13G filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.